Snak Yosinta, Widayati Kartika, Arfian Nur, Anggorowati Nungki
Department of Anatomical Pathology, 2Division of Hematology Oncology, Department of Internal Medicine, 3Department of Anatomy, Faculty of Medicine, Universitas Gadjah Mada/Sardjito Hospital, Yogyakarta, Indonesia. Email:
Asian Pac J Cancer Prev. 2018 Jan 27;19(1):185-191. doi: 10.22034/APJCP.2018.19.1.185.
Objective: The diffuse large B-cell lymphoma (DLBCL) has two major molecular subtypes, germinal center B-cell-like (GCB) and non-GCB. These have differing behavior which affects overall patient survival. However, immunohistochemistry based molecular subtyping of Indonesian DLBCLs has been limited. This was the focus of the present study, with a focus of attention on the apoptotic index (AI) and the proliferation index (PI) of the two molecular subtypes. Materials and Methods: During the study period of 3.5 years, a total of 98 cases of DLBCL were identified. Molecular subtypes and PI were determined by immunohistochemistry and TUNEL method was used to determine the AI. Result: GCB accounted for 31 cases (31.6%) and non-GCB the remainder (68.4%). Gender showed a slight male predominance (54 cases, 55.1%), with a higher incidence in the extra-nodal region (57 cases, 58.2%). The AI and PI were significantly higher in GCB (p<0.001 in the Mann-Whitney test) and a Spearman correlation coefficient test showed that PI was positively correlated with AI (r=0.673, p<0.001). Conclusion: The findings indicate that the non-GCB subtype is more common than GCB in Indonesian DLBCL. GCB features significantly higher PI and AI, which themselves appear linked.
弥漫性大B细胞淋巴瘤(DLBCL)有两种主要分子亚型,生发中心B细胞样(GCB)和非GCB。它们具有不同的行为,这会影响患者的总体生存。然而,基于免疫组织化学的印度尼西亚DLBCL分子亚型分类一直很有限。这是本研究的重点,重点关注两种分子亚型的凋亡指数(AI)和增殖指数(PI)。材料与方法:在3.5年的研究期间,共鉴定出98例DLBCL。通过免疫组织化学确定分子亚型和PI,采用TUNEL法测定AI。结果:GCB占31例(31.6%),其余为非GCB(68.4%)。性别上男性略占优势(54例,55.1%),结外区域发病率较高(57例,58.2%)。GCB中的AI和PI显著更高(曼-惠特尼检验p<0.001),Spearman相关系数检验显示PI与AI呈正相关(r=0.673,p<0.001)。结论:研究结果表明,在印度尼西亚DLBCL中,非GCB亚型比GCB更常见。GCB的PI和AI显著更高,且它们似乎相互关联。